Australia has a well-documented problem commercialising scientific research. We rank highly in academic publications and research quality, but poorly in turning that research into viable businesses. The gap is particularly pronounced in deep tech—the hard science ventures that require significant capital and long development timelines before reaching market.

I’ve spent the last month talking to founders, investors, and research commercialisation offices trying to understand where the system breaks down. The answer isn’t simple, but there’s a clear pattern: Australian deep tech startups can get initial funding relatively easily, but they hit a wall when trying to scale.

The Early Stage Is Actually Fine

Contrary to popular belief, early-stage deep tech funding in Australia isn’t terrible. University commercialisation grants, CSIRO programs, state government innovation funds, and organisations like the Medical Research Future Fund provide seed capital for research translation.

A quantum computing spinout from UNSW or a biotech venture from the University of Melbourne can usually secure a few hundred thousand dollars to validate their technology and build a prototype. The problem comes later.

The Series A Cliff

Australian venture capital is concentrated in B2B SaaS and fintech—sectors with relatively fast time to revenue and clear exit paths. Deep tech ventures typically need three to five years before generating meaningful revenue, which doesn’t fit the standard VC fund timeline.

One founder I spoke with developed advanced battery technology at Monash University. They successfully commercialised the research, built a working prototype, and secured pilot customers. When they went looking for Series A funding to scale manufacturing, they found almost no Australian investors willing to write a large enough cheque for hardware deep tech.

They eventually raised from a US fund, but had to relocate significant operations to California as a condition of investment. Australia funded the research and the early translation, then watched the value creation move offshore.

This pattern repeats constantly across quantum computing, advanced materials, biotech, and clean energy ventures.

Why Australian VCs Avoid Deep Tech

The reluctance to fund deep tech isn’t irrational. These investments are genuinely higher risk and require more patient capital than most VC funds can accommodate.

A typical Australian VC fund has a 7-10 year timeline to return capital to limited partners. Deep tech ventures often need 5-7 years just to reach commercialisation. That leaves almost no time for the growth phase that generates VC-scale returns.

Deep tech also requires specialised due diligence. Evaluating a quantum computing startup demands technical expertise that most generalist VCs don’t have. Without the ability to properly assess the technology risk, investors default to passing.

And there’s the exit problem. Australian IPO markets aren’t particularly welcoming to pre-revenue deep tech companies, and strategic acquisition opportunities are limited because we have fewer large technology companies than the US.

The UK and European Comparison

It’s worth looking at how other similar-sized economies handle this. The UK has programmes like the Future Fund and Innovate UK that provide significant capital specifically for deep tech scale-up. These aren’t small grants—they’re equity investments and loans in the millions to tens of millions of pounds.

Germany’s Fraunhofer Institutes bridge the gap between university research and commercial application, de-risking technologies before they reach the private funding market. The European Investment Bank provides long-term debt financing for capital-intensive deep tech ventures.

Australia has some equivalent programmes—CSIRO’s Main Sequence Ventures, the Clean Energy Finance Corporation, and various state-based funds—but the total capital available is much smaller relative to the opportunity.

The Brain Drain Feedback Loop

When deep tech ventures can’t scale in Australia, the best ones move to markets with better funding access. This creates a feedback loop that makes the problem worse.

Every successful deep tech company that relocates represents a missed opportunity for Australia to develop local expertise in that sector. It means there are fewer experienced deep tech operators who might later become investors or advisors. It means less talent development in advanced technology sectors.

The founders who stay in Australia often have to compromise their ambitions, building smaller businesses than the technology could support simply because capital isn’t available.

What Actually Needs to Change

First, we need more patient capital specifically structured for deep tech timelines. This probably requires government co-investment vehicles that can anchor larger rounds and provide longer timelines than traditional VC funds.

Second, we need better specialisation among investors. Instead of generalist VCs occasionally dipping into deep tech, we need funds with genuine technical expertise in specific sectors like quantum, advanced materials, or biotech.

Third, the super funds need to step up. Australian superannuation holds over three trillion dollars but allocates almost nothing to local venture capital and especially not to deep tech. Even a small percentage shift could transform the funding landscape.

Fourth, we need better pathways to scale manufacturing and commercialisation domestically. Too many deep tech ventures hit scaling problems not just from capital constraints but from lack of local manufacturing partners and supply chain infrastructure.

The Strategic Importance

This isn’t just about startup funding. Deep tech is increasingly strategic for economic and national security. Quantum computing, advanced manufacturing, clean energy, and biotechnology are all sectors where leading countries will have significant advantages.

Australia is currently positioned to be a research supplier—we do the science, publish the papers, and then watch other countries commercialise the results. That’s a terrible position economically and strategically.

We have all the ingredients to be competitive in deep tech: world-class universities, talented researchers, and sufficient early-stage support. What we’re missing is the follow-through capital to turn promising research into scaled businesses.

The funding gap isn’t insurmountable, but it requires deliberate policy choices and investment capital deployment. Other countries have figured this out. Australia can too, but the window is narrowing.